This public procurement record has 2 releases in its history.

Award

22 Apr 2025 at 16:48

Tender

08 Nov 2024 at 12:00

Summary of the contracting process

The NHS Framework Agreement for Branded Medicines in the Proprietary Category Tender, facilitated by NHS England, is a public procurement process focused on pharmaceutical products. The procurement is being handled through an open procedure and falls under the "goods" category. The agreement is scheduled to run from 1st May 2025 to 30th April 2029, covering the entire UK region. The tender stage is currently active, with a submission deadline of 9th December 2024 at 13:00. This framework is notable for its significant value, amounting to £1,775,939,000, and it supports electronic submission methods through dedicated platforms.

This procurement presents substantial opportunities for businesses operating within the pharmaceutical industry, particularly those supplying branded medicines. Large companies and SMEs alike, such as Norgine Pharmaceuticals Limited and Novartis Pharmaceuticals UK Ltd, have successfully participated in similar NHS tenders and continue to provide value. SMEs in particular should consider this opportunity, given that NHS procurement processes often encourage SME participation, evidenced by the significant number of respondents from this segment. Businesses that utilise electronic systems for procurement and have robust delivery capabilities throughout the UK will find this framework advantageous for strategic growth and service expansion across NHS networks.

How relevant is this notice?

Notice Information

Notice Title

NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 1 May 2025

Notice Description

Invitation to offer for NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 01 May 2025<br/>Offer reference number: CM/PHR/22/5683<br/><br/>CM/PHR/22/5683/00 - NHS Framework Agreement for Branded Medicines - Proprietary Category Tender:<br/>Period of Framework Agreement: 01 May 2025 to 30 April 2029

Lot Information

Lot 1

Invitation to offer for NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 01 May 2025
Offer reference number: CM/PHR/22/5683

CM/PHR/22/5683/00 - NHS Framework Agreement for Branded Medicines - Proprietary Category Tender:
Period of Framework Agreement: 01 May 2025 to 30 April 2029. Additional information: Price is not the only award criterion and all award criteria are stated only in the award documents

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-04b505
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/016340-2025
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£1,775,939,000 £1B-£10B
Lots Value
£1,775,939,000 £1B-£10B
Awards Value
Not specified
Contracts Value
£1

Notice Dates

Publication Date
22 Apr 20251 years ago
Submission Deadline
9 Dec 2024Expired
Future Notice Date
Not specified
Award Date
Not specified
Contract Period
1 May 2025 - 30 Apr 2029 4-5 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LEEDS
Postcode
LS1 4AP
Postcode Area
Leeds
Country
England

Major Region (ITL 1)
TLE Yorkshire and The Humber
Basic Region (ITL 2)
TLE4 West Yorkshire
Small Region (ITL 3)
TLE42 Leeds
Delivery Location
Not specified

Local Authority
Leeds
Electoral Ward
Hunslet & Riverside
Westminster Constituency
Leeds South

Supplier Information

Number of Suppliers
72
Supplier Names

Norgine Pharmaceuticals Limited

Rayner Surgical Group Ltd

Napp Pharmaceuticals Ltd

Gedeon Richter UK Ltd

Tillomed Laboratories ltd

Alissa Healthcare Research Limited

Novartis Pharmaceuticals UK Ltd

Eisai Ltd

Aspen Pharmacare UK Limited

Ferring Pharmaceuticals Ltd

Theramex HQ UK

G.L. Pharma UK Limited

Ridge Pharma

Nordic Pharma

Strandhaven Ltd

Xiromed

Novo Nordisk

Intrapharm Laboratories Ltd

Aventis Pharma ltd

Galen Ltd

Grunenthal

Drugsrus Ltd

SERB SA

Orifarm UK

Merck Serono Limited

Astellas Pharma Ltd

Besins Healthcare UK LTD

Dexcel Pharma Ltd

Pharmasure Ltd

Ipsen

Janssen-Cilag Ltd

Pharming Group

Baxter Healthcare Ltd

Chiesi Limited

Otsuka Pharmaceuticals UK Limited

CST Pharma Limited

Selective Supplies Ltd

Glenmark Pharmaceuticals Europe Ltd

Wockhardt UK Limited

ROVI Biotech Ltd

Essential Pharma

Bayer Plc

BioCryst Ireland Limited

Kyowa Kirin International NewCo Ltd

Neuraxpharm UK Ltd

Organon Pharmaceuticals UK Ltd

Provepharm UK Ltd

Colonis Pharma Ltd

Accord-UK Ltd

Neon Healthcare Ltd

Ranbaxy (UK) Ltd

Sandoz Ltd

Teva UK Limited

Recordati Rare Diseases UK Ltd

medac Pharma LLP

Synchrony

Infectopharm (UK) Ltd

Mercury Pharmaceuticals Limited

Merz

Pfizer Ltd

Takeda UK Ltd

Aspire Pharma Ltd

Zentiva Pharma UK Ltd

Day Lewis Medical Ltd

Morningside Pharmaeuticals

Celix Pharma Ltd.

Lupin Healthcare (UK) Limited

Abbvie Ltd

Mylan

CSL Behring UK Ltd

FLYNN PHARMA LTD

Thornton and Ross Ltd

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...